VenoStent, Inc.

Developing bioresorbable smart polymer scaffolds to transform vascular surgery

General Information
Company Name
VenoStent, Inc.
Founded Year
2017
Location (Offices)
Houston, United States +1
Founders / Decision Makers
Number of Employees
30
Industries
Biotechnology, Health Care, Life Sciences +2
Funding Stage
Series A
Social Media

VenoStent, Inc. - Company Profile

VenoStent, Inc. is a clinical stage medical device and tissue engineering company founded in 2017. The company specializes in developing bioresorbable smart polymer scaffolds aimed at revolutionizing outcomes in vascular surgery. VenoStent recently received a significant $16.00M Series A investment on 31 July 2023, demonstrating strong investor confidence. The investment was led by a consortium of notable firms including Creative Ventures, Good Growth Capital, Cowtown Angels, Alumni Ventures Blockchain Fund, IAG Capital Partners, SNR, TMC Venture Fund, and Baylor Angel Network. With its focus on biotechnology and healthcare, VenoStent remains at the forefront of innovation in the United States, showcasing promising potential for disruption in the medical technology sector.

Taxonomy: medical device, clinical stage, tissue engineering, vascular surgery, bioabsorbable wraps, smart polymer scaffolds

Funding Rounds & Investors of VenoStent, Inc. (12)

View All
Funding Stage Amount No. Investors Investors Date
Series A $4.00M 3 27 Jun 2024
Grant $3.60M 1 National Institutes of Health 27 Jun 2024
Series A $16.00M 8 TMC Venture Fund, Baylor Angel Network +1 31 Jul 2023
Seed Round $3.00M 8 Olima Ventures 23 Feb 2021
Seed Round $150.00K 1 25 Aug 2020

View All 12 Funding Rounds

Latest News of VenoStent, Inc.

View All

No recent news or press coverage available for VenoStent, Inc..

Similar Companies to VenoStent, Inc.

View All

No funding or investment information available for VenoStent, Inc. at this time.